"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
Descriptor ID |
D000900
|
MeSH Number(s) |
D27.505.954.122.085
|
Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 1 | 4 |
1996 | 4 | 2 | 6 |
1997 | 3 | 2 | 5 |
1998 | 6 | 0 | 6 |
1999 | 3 | 2 | 5 |
2000 | 3 | 0 | 3 |
2001 | 3 | 1 | 4 |
2002 | 4 | 3 | 7 |
2003 | 5 | 1 | 6 |
2004 | 2 | 2 | 4 |
2005 | 8 | 3 | 11 |
2006 | 6 | 3 | 9 |
2007 | 6 | 2 | 8 |
2008 | 4 | 2 | 6 |
2009 | 3 | 4 | 7 |
2010 | 5 | 3 | 8 |
2011 | 6 | 7 | 13 |
2012 | 6 | 3 | 9 |
2013 | 7 | 6 | 13 |
2014 | 3 | 1 | 4 |
2015 | 9 | 4 | 13 |
2016 | 10 | 10 | 20 |
2017 | 5 | 11 | 16 |
2018 | 9 | 9 | 18 |
2019 | 7 | 4 | 11 |
2020 | 5 | 7 | 12 |
2021 | 3 | 11 | 14 |
2022 | 4 | 9 | 13 |
2023 | 2 | 12 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Emergency medicine updates: Acute diverticulitis. Am J Emerg Med. 2024 Feb; 76:1-6.
-
Bayesian modeling of the impact of antibiotic resistance on the efficiency of MRSA decolonization. PLoS Comput Biol. 2023 Oct; 19(10):e1010898.
-
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA. 2023 10 10; 330(14):1337-1347.
-
The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales. Front Cell Infect Microbiol. 2023; 13:1249505.
-
Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2023 Dec; 44(12):1901-1908.
-
Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics: A Secondary Analysis of the CODA Randomized Clinical Trial. JAMA Surg. 2023 09 01; 158(9):901-908.
-
Distinct Origins and Transmission Pathways of blaKPCEnterobacterales across Three U.S. States. J Clin Microbiol. 2023 08 23; 61(8):e0025923.
-
Management of ACL Reconstruction Complicated by MRSA Osteomyelitis Requiring a Gastrocnemius Perforator Flap: A Case Report. JBJS Case Connect. 2023 07 01; 13(3).
-
Electrophoretic deposition of gentamicin and chitosan into titanium nanotubes to target periprosthetic joint infection. J Biomed Mater Res B Appl Biomater. 2023 09; 111(9):1697-1704.
-
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites. Microbiol Spectr. 2023 06 15; 11(3):e0413422.